OpGen Inc
General ticker "OPGN" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $7.7M
OpGen Inc does not follow the US Stock Market performance with the rate: -32.9%.
Estimated limits based on current volatility of 17.7%: low 0.64$, high 0.92$
Factors to consider:
- US accounted for 20.0% of revenue in the fiscal year ended 2022-12-31
- Current price 51.8% below estimated low
- Earnings for 18 months up through Q2 (+1 year) exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2022-12-31 to 2024-12-30
- 2022-12-31 to 2023-12-31 estimated range: [5.68$, 33.36$]
- 2023-12-31 to 2024-12-30 estimated range: [1.47$, 8.19$]
Financial Metrics affecting the OPGN estimates:
- Negative: Non-GAAP EPS, $ of -105.00 <= 0.10
- Negative: Operating profit margin, % of -92.99 <= 1.03
- Negative: Operating cash flow per share per price, % of -73.79 <= 2.35
- Negative: negative Net income
- Negative: Industry operating cash flow per share per price (median), % of -21.66 <= 3.85
- Negative: Inventory ratio change, % of 9.22 > 1.08
- Negative: Industry earnings per price (median), % of -24.66 <= 1.31
- Negative: Industry operating profit margin (median), % of -98.17 <= 2.14
- Negative: Interest expense per share, $ of 13.34 > 0.74
Short-term OPGN quotes
Long-term OPGN plot with estimates
Financial data
| YTD | 2021-12-31 | 2022-12-31 | 2023-12-31 |
|---|---|---|---|
| Operating Revenue | $4.31MM | $2.61MM | $3.42MM |
| Operating Expenses | $27.58MM | $37.17MM | $19.11MM |
| Operating Income | $-23.27MM | $-34.57MM | $-15.69MM |
| Non-Operating Income | $-11.49MM | $-2.72MM | $-16.98MM |
| Interest Expense | $4.80MM | $3.26MM | $1.84MM |
| R&D Expense | $10.91MM | $8.17MM | $4.73MM |
| Income(Loss) | $-34.76MM | $-37.28MM | $-32.67MM |
| Taxes | $0.04MM | $0.00MM | $0.00MM |
| Profit(Loss) | $-34.81MM | $-37.28MM | $-32.67MM |
| Stockholders Equity | $41.22MM | $7.58MM | $-11.56MM |
| Inventory | $1.24MM | $1.35MM | $0.00MM |
| Assets | $71.67MM | $25.81MM | $1.88MM |
| Operating Cash Flow | $-21.48MM | $-20.45MM | $-14.32MM |
| Capital expenditure | $1.98MM | $0.59MM | $0.80MM |
| Investing Cash Flow | $-1.98MM | $-0.59MM | $-0.80MM |
| Financing Cash Flow | $47.45MM | $-6.74MM | $8.37MM |
| Earnings Per Share* | $-189.81 | $-150.49 | $-41.47 |
* EPS are Split Adjusted, recent splits may be reflected with a delay.